JENNIFER M CARANDANG
Allopathic & Osteopathic Physicians|Internal Medicine AVON, OH NPI 1912909862
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine OH ABBVIE INC. All categories
General Payments — all program years on this page
$6,351.90
- Category: General Payments
- Program years: PY2018–2024
- Record count: 336
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,523.57 across 74 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,523.57 | 74 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $422.51 | 26 |
| Corcept Therapeutics | $186.49 | 7 |
| Acerta Pharma LLC | $168.68 | 5 |
| Amgen Inc. | $138.96 | 3 |
| Axsome Therapeutics, Inc. | $63.28 | 2 |
| PFIZER INC. | $55.84 | 3 |
| GlaxoSmithKline, LLC. | $49.14 | 3 |
| Novo Nordisk AS | $45.86 | 3 |
| DEXCOM, INC. | $45.56 | 2 |
| Lilly USA, LLC | $41.83 | 3 |
| Janssen Pharmaceuticals, Inc | $38.46 | 2 |
| Corium, Inc. | $34.95 | 1 |
| Teva Pharmaceuticals USA, Inc. | $33.71 | 2 |
| Merck Sharp & Dohme Corporation | $33.50 | 2 |
| Ardelyx, Inc. | $33.29 | 2 |
| Antares Pharma, Inc. | $20.66 | 1 |
| ACADIA Pharmaceuticals Inc | $19.99 | 1 |
| OptiNose US, Inc. | $18.15 | 1 |
| Xeris Pharmaceuticals, Inc. | $17.78 | 1 |
| Exact Sciences Corporation | $14.56 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.67 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.63 | 1 |
| Amneal Pharmaceuticals LLC | $13.07 | 1 |
By program year
Records — PY2024 (74)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.